                         SEQUENCE LISTING

<110>  Janssen Pharmaceutica NV
       Johnson & Johnson (China) Investment Ltd.
 
<120>  HETEROARYLDIHYDROPYRIMIDINE DERIVATIVES AND METHODS OF TREATING 
       HEPATITIS B INFECTIONS

<130>  P2019TC978

<150>  PCT/CN2018/122258
<151>  2018-12-20

<150>  US 62/791,576
<151>  2019-01-11

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial

<220>
<223>  primer

<400>  1
gtgtctgcgg cgttttatca                                                   20


<210>  2
<211>  21
<212>  DNA
<213>  Artificial

<220>
<223>  primer

<400>  2
gacaaacggg caacatacct t                                                 21


<210>  3
<211>  28
<212>  DNA
<213>  Artificial

<220>
<223>  probe

<400>  3
cctctkcatc ctgctgctat gcctcatc                                          28


